US Patent Issued to Valneva Austria, Valneva USA on June 10 for "Isolated polypeptide of the toxin a and toxin B proteins of C. difficile and uses thereof" (Austrian, American Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,324,831, issued on June 10, was assigned to Valneva Austria GmbH (Vienna) and Valneva USA Inc. (Gaithersburg, Md.).

"Isolated polypeptide of the toxin a and toxin B proteins of C. difficile and uses thereof" was invented by Larry R. Ellingsworth (Rockville, Md.), David Flyer (Olney, Md.), Jing-Hui Tian (Germantown, Md.), Steven R. Fuhrmann (Germantown, Md.), Stefanie Kluepfel-Stahl (Bethesda, Md.), Gregory M. Glenn (Gaithersburg, Md.) and Kerstin Westritschnig (Vienna).

According to the abstract* released by the U.S. Patent & Trademark Office: "This present invention provides C-TAB.G5 and C-TAB.G5.1 isolated polypeptides comprising the receptor binding domains of C. difficile toxin A...